Metastatic carcinoma of the cervix with unexpected ovarian involvement: A rare case report and review of the literature
- PMID: 40669199
- PMCID: PMC12281432
- DOI: 10.1016/j.ijscr.2025.111605
Metastatic carcinoma of the cervix with unexpected ovarian involvement: A rare case report and review of the literature
Abstract
Introduction and importance: Ovarian metastasis from cervical carcinoma (CC) is rare. As adenocarcinomas tend to develop within the endocervix, they may be hidden in Pap tests and have a normal Colposcopic appearance. Only a limited number of Ovarian metastases from CC are reported in the literature, and various aspects of this involvement still need to be clarified.
Presentation: In this study, we reported a case of unexpected ovarian metastatic cervical cancer in a 57-year-old female. The uniqueness of the present case was the large size of the metastatic ovarian mass, which led to ureter compression from the AC and the good response to chemoradiotherapy. Unlike the previously reported cases in which the ureter was obstructed at the ureter-bladder junction(trigone), in our case, ureter obstruction occurred at the level of the pelvic brim.
Clinical discussion: Even though ovarian metastasis of cervical cancer is rare, chemoradiotherapy (CRT) manifests a good response with no remnant cervical mass observed in the surgery, which is compatible with the result of a normal Positron emission tomography scan (PET).
Conclusion: Cervical adenocarcinoma can often be diagnosed at very late stages, presenting with large ovarian masses and symptoms of ureter compression. This highlights a lack of awareness regarding appropriate cervical cancer screening tests. Moreover, there is a need for appropriate following imaging methods to differentiate pelvic masses and lymph nodes.
Keywords: Cervical adenocarcinoma; Ovarian involvement; Positron emission tomography scan.
Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest There are no conflicts of interest to disclose.
Figures





Similar articles
-
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2. Cochrane Database Syst Rev. 2015. PMID: 26417712 Free PMC article.
-
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866378 Free PMC article.
-
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.Cochrane Database Syst Rev. 2016 Mar 1;3(3):CD010360. doi: 10.1002/14651858.CD010360.pub2. Cochrane Database Syst Rev. 2016. PMID: 26930463 Free PMC article.
-
Interventions targeted at women to encourage the uptake of cervical screening.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3. Cochrane Database Syst Rev. 2021. PMID: 34694000 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Hodgson A., Olkhov-Mitsel E., Howitt B.E., Nucci M.R., Parra-Herran C. International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome. J. Clin. Pathol. 2019;72(5):347–353. - PubMed
-
- Rodriguez-Carunchio L., Soveral I., Steenbergen R., Torné A., Martinez S., Fusté P., et al. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis. BJOG. 2015;122(1):119–127. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials